Drug - Alupent
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Metaproterenol Sulfate
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Metaproterenol Sulfate. May repeat for multiple part products.

The firm name holding legal responsibility for Alupent. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 015874
The FDA assigned number to Alupent. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Alupent. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Alupent was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Alupent. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Alupent is in. Format is RX, OTC, DISCN.

Applicant Full Name - Boehringer Ingelheim Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Alupent.